Akio Tawa

4.5k total citations
96 papers, 2.5k citations indexed

About

Akio Tawa is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Akio Tawa has authored 96 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 44 papers in Public Health, Environmental and Occupational Health and 25 papers in Molecular Biology. Recurrent topics in Akio Tawa's work include Acute Myeloid Leukemia Research (57 papers), Acute Lymphoblastic Leukemia research (44 papers) and Hematopoietic Stem Cell Transplantation (12 papers). Akio Tawa is often cited by papers focused on Acute Myeloid Leukemia Research (57 papers), Acute Lymphoblastic Leukemia research (44 papers) and Hematopoietic Stem Cell Transplantation (12 papers). Akio Tawa collaborates with scholars based in Japan, United States and Canada. Akio Tawa's co-authors include Junichi Hara, Keisei Kawa‐Ha, Keiko Yumura‐Yagi, Shigehiko Ishihara, Keizo Horibe, Shintaro Okada, Yuko Osugi, Gaku Hosoi, Ichiro Tsukimoto and Masahiro Tsuchida and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Akio Tawa

93 papers receiving 2.4k citations

Peers

Akio Tawa
Hisashi Gondo Japan
Carmella van de Ven United States
Kazuko Kudo Japan
R. Arnold Germany
Alfred P. Gillio United States
Iskra Pusic United States
Masahiro Sako Japan
Margit Mitterbauer Austria
Fen Huang China
Yoshihisa Kodera Japan
Hisashi Gondo Japan
Akio Tawa
Citations per year, relative to Akio Tawa Akio Tawa (= 1×) peers Hisashi Gondo

Countries citing papers authored by Akio Tawa

Since Specialization
Citations

This map shows the geographic impact of Akio Tawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akio Tawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akio Tawa more than expected).

Fields of papers citing papers by Akio Tawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akio Tawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akio Tawa. The network helps show where Akio Tawa may publish in the future.

Co-authorship network of co-authors of Akio Tawa

This figure shows the co-authorship network connecting the top 25 collaborators of Akio Tawa. A scholar is included among the top collaborators of Akio Tawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akio Tawa. Akio Tawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sano, Hirozumi, Keitaro Fukushima, Michihiro Yano, et al.. (2024). Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study. International Journal of Hematology. 119(6). 745–754.
2.
Aoki, Takahiro, Norio Shiba, Shin‐ichi Tsujimoto, et al.. (2023). High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factor. Pediatric Blood & Cancer. 71(2). e30803–e30803. 5 indexed citations
3.
Yamagishi, Takuya, Mari Matsui, Tsuyoshi Sekizuka, et al.. (2020). A prolonged multispecies outbreak of IMP-6 carbapenemase-producing Enterobacterales due to horizontal transmission of the IncN plasmid. Scientific Reports. 10(1). 4139–4139. 27 indexed citations
4.
5.
Miyamura, Takako, Hiroshi Moritake, Hideki Nakayama, et al.. (2019). Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study. British Journal of Haematology. 185(2). 284–288. 15 indexed citations
6.
Iijima‐Yamashita, Yuka, H. Matsuo, Miho Yamada, et al.. (2017). Multiplex fusion gene testing in pediatric acute myeloid leukemia. Pediatrics International. 60(1). 47–51. 9 indexed citations
7.
Matsuo, H., Yuka Iijima‐Yamashita, Miho Yamada, et al.. (2017). Monitoring of fusion gene transcripts to predict relapse in pediatric acute myeloid leukemia. Pediatrics International. 60(1). 41–46. 12 indexed citations
8.
Hori, Hiroki, Tooru Kudoh, Shin‐Ichiro Nishimura, et al.. (2016). Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study. International Journal of Clinical Oncology. 22(2). 387–396. 10 indexed citations
9.
Miyamura, Takako, Katsuyoshi Koh, Takashi Taga, et al.. (2015). Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of the Japanese Pediatric Leukemia/Lymphoma Study Group. International Journal of Hematology. 102(6). 697–701. 6 indexed citations
10.
Mitani, Sachiyo, Norio Shiba, Y Hayashi, et al.. (2015). High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML. Leukemia. 29(5). 1076–1083. 37 indexed citations
11.
Matsuo, H., Daisuke Tomizawa, Tomoyuki Watanabe, et al.. (2014). Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Blood Cancer Journal. 4(7). e226–e226. 17 indexed citations
12.
Tomizawa, Daisuke, Akio Tawa, Tomoyuki Watanabe, et al.. (2013). Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. International Journal of Hematology. 98(5). 578–588. 37 indexed citations
13.
Adachi, Souichi, Atsushi Manabe, Masue Imaizumi, et al.. (2007). Acute Myeloid Leukemia with Multilineage Dysplasia in Children. International Journal of Hematology. 86(4). 358–363. 5 indexed citations
14.
Kobayashi, Ryōji, Akio Tawa, Ryoji Hanada, et al.. (2006). Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia. Pediatric Blood & Cancer. 48(4). 393–398. 75 indexed citations
15.
Yumura‐Yagi, Keiko, Junichi Hara, Hiroki Kurahashi, et al.. (1992). Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome. British Journal of Haematology. 81(4). 520–525. 31 indexed citations
16.
Hara, Junichi, Keiko Yumura‐Yagi, S Tagawa, et al.. (1990). Molecular analysis of T cell receptor and CD3 genes in CD3- large granular lymphocytes (LGLs): evidence for the existence of CD3- LGLs committed to the T cell lineage.. PubMed. 4(8). 580–3. 7 indexed citations
17.
Tawa, Akio, Masami Inoue, Shigehiko Ishihara, et al.. (1990). Increased expression of the multidrug-resistance gene in undifferentiated sarcoma. Cancer. 66(9). 1980–1983. 14 indexed citations
18.
Yumura‐Yagi, Keiko, Shigehiko Ishihara, Junichi Hara, et al.. (1989). Poor prognosis of mediastinal non-Hodgkin's lymphoma with an immature phenotype of CD2+, CD7 (or CD5)+, CD3−, CD4−, and CD8−. Cancer. 63(4). 671–674. 8 indexed citations
19.
Ishihara, Shigehiko, Akio Tawa, Keiko Yumura‐Yagi, et al.. (1989). Clonal T‐cell Lymphoproliferation Containing Epstein‐Barr (EB) Virus DNA in a Patient with Chronic Active EB Virus Infection. Japanese Journal of Cancer Research. 80(2). 99–101. 60 indexed citations
20.
Kitano, Yukio, et al.. (1982). Malignant Lymphoma with the Skin Lesion in a Child. Skin research. 24(2). 212–216. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisashi Gondo Breakdown of academic impact, for papers by Carmella van de Ven Breakdown of academic impact, for papers by Kazuko Kudo Breakdown of academic impact, for papers by R. Arnold Breakdown of academic impact, for papers by Alfred P. Gillio Breakdown of academic impact, for papers by Iskra Pusic Breakdown of academic impact, for papers by Masahiro Sako Breakdown of academic impact, for papers by Margit Mitterbauer Breakdown of academic impact, for papers by Fen Huang Breakdown of academic impact, for papers by Yoshihisa Kodera
Rankless by CCL
2026